Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jocelyn San Mateo"'
Autor:
Peter L. Collins, Cindy Luongo, Jocelyn San Mateo, Ursula J. Buchholz, Ruth A. Karron, Kimberli Wanionek
Publikováno v:
J Infect Dis
The Journal of Infectious Diseases
The Journal of Infectious Diseases
Background Respiratory syncytial virus (RSV) is the leading global cause of severe pediatric acute respiratory tract illness, and a vaccine is needed. RSV/ΔNS2/Δ1313/I1314L contains 2 attenuating elements: (1) deletion of the interferon antagonist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a45d42d4e5da81b8468b61617435a42
https://doi.org/10.1093/infdis/jiz408
https://doi.org/10.1093/infdis/jiz408
Autor:
Karron, Ruth A.1 rkarron@jhu.edu, Jocelyn San Mateo1, Wanionek, Kimberli1, Collins, Peter L.2, Buchholz, Ursula J.2
Publikováno v:
Journal of the Pediatric Infectious Diseases Society. Mar2018, Vol. 7 Issue 1, p86-89. 4p.
Publikováno v:
Journal of the Pediatric Infectious Diseases Society
We conducted a phase I clinical trial of an experimental live attenuated recombinant human metapneumovirus (HMPV) vaccine (rHMPV-Pa) sequentially in adults, HMPV-seropositive children, and HMPV-seronegative children, the target population for vaccina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f17d94d443eb92f5621c247d10fd92c
Autor:
Bhagvanji Thumar, Ruth A. Karron, Brian R. Murphy, Ursula J. Buchholz, Jocelyn San Mateo, Alexander C. Schmidt, Anne Schaap-Nutt, Peter L. Collins, Emmalene J. Bartlett
We conducted a phase I clinical trial (clinicaltrials.gov identifier, NCT00641017) of the experimental live-attenuated human parainfluenza virus type 1 (HPIV-1) vaccine rHPIV-1/84/del 170/942A sequentially in 3 groups: adults, HPIV-1-seropositive chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5df676ccf84da5530b6c8976add23536
https://europepmc.org/articles/PMC4681387/
https://europepmc.org/articles/PMC4681387/
